Literature DB >> 7137165

Clinical, hematological, and biochemical features of Hb SC disease.

S K Ballas, C N Lewis, A M Noone, S H Krasnow, E Kamarulzaman, E R Burka.   

Abstract

Twenty-seven patients were seen and followed at our Sickle Cell Center over a period of seven years. Their clinical, hematological, and biochemical features were determined and compared to those of patients with sickle cell anemia who were concurrently investigated. The data indicate that the mild anemia of hemoglobin (Hb) SC disease is slightly microcytic and hyperchromatic. Parameters of hemolysis and the complications of chronic hemolytic anemia (cholelithiasis, leg ulcers, hepatomegaly, and cardiomegaly) are milder in Hb SC disease than in sickle cell anemia. Asplenia and its sequelae (increased platelet count and reduced serum IgM levels) are less frequent in Hb SC disease. Cerebrovascular accidents and the decreased leukocyte alkaline phosphatase scores are similar in both diseases. Thromboembolic complications, retinopathy, and renal papillary necrosis are more frequent in Hb SC disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137165     DOI: 10.1002/ajh.2830130106

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Authors:  Stéphane Maurel; Katia Stankovic Stojanovic; Virginie Avellino; Alexey Girshovich; Emmanuel Letavernier; Gilles Grateau; Laurent Baud; Robert Girot; Francois Lionnet; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

3.  Evidence supporting a single origin of the beta(C)-globin gene in blacks.

Authors:  C D Boehm; C E Dowling; S E Antonarakis; G R Honig; H H Kazazian
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

Review 4.  Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Authors:  Rakhi P Naik; Michael B Streiff; Sophie Lanzkron
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

5.  Hickam's dictum and the rare convergence of antisynthetase syndrome and hemoglobin SC disease.

Authors:  S T Wilkinson; M R Grunwald; J J Paik; L W Ostrow; A C Gelber
Journal:  QJM       Date:  2014-12-16

6.  Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.

Authors:  Tiffany T Yu; Julie Nelson; Michael B Streiff; Sophie Lanzkron; Rakhi P Naik
Journal:  Thromb Res       Date:  2016-03-02       Impact factor: 3.944

7.  Nucleosomes and neutrophil activation in sickle cell disease painful crisis.

Authors:  Marein Schimmel; Erfan Nur; Bart J Biemond; Gerard J van Mierlo; Shabnam Solati; Dees P Brandjes; Hans-Martin Otten; John-John Schnog; Sacha Zeerleder
Journal:  Haematologica       Date:  2013-08-02       Impact factor: 9.941

8.  Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.

Authors:  A D Blann; J S Mohan; D Bareford; G Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2007-12-14       Impact factor: 2.300

9.  Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico study.

Authors:  Misaki Wayengera
Journal:  BMC Blood Disord       Date:  2012-05-14

10.  An eye on sickle cell retinopathy.

Authors:  Mônica Barbosa de Melo
Journal:  Rev Bras Hematol Hemoter       Date:  2014-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.